Cytokine panels in the treatment and diagnosis of rheumatic diseases: current practices and future promise

Elliot A. Philips, Sara Stream, Michael H. Pillinger, Jonathan Samuels · 2026

Read Cytokine panels in the treatment and diagnosis of rheumatic diseases: current practices and future promise by Elliot A. Philips, Sara Stream, Michael H. Pillinger, Jonathan Samuels (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13626583.txt.

Description

Elliot Philips and co-authors review the use of cytokine panels in rheumatic disease care, in a paper from 2026. Cytokines are signaling proteins that drive inflammation. A panel measures a set of them in blood at once, giving a snapshot of a patient's inflammatory state.

Use of the panels surged during the COVID-19 pandemic, when severe cases showed extreme cytokine storms. Doctors kept ordering them as the pandemic faded, for other inflammatory syndromes. The review weighs where the panels help diagnosis and treatment today. It also marks where proof is still thin. The authors argue the panels hold promise, but more research must pin down which diseases and moments justify their use.

Catalog record

CREATORElliot A. Philips, Sara Stream, Michael H. Pillinger, Jonathan Samuels
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE16 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13626583

Browse the full library · About the Tower of Babel